Richard L. Dunbar, M.D.
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Penn-Presbyterian Medical Center
4th Floor, Andrew Mutch Building
51 North 39th Street
Philadelphia, PA 19104-2699
4th Floor, Andrew Mutch Building
51 North 39th Street
Philadelphia, PA 19104-2699
Office: Clinic (215) 615-8659
Publications
Links
Search PubMed for articles
Cardiovascular Institute (CVI)
Institute for Translational Medicine and Therapeutics (ITMAT)
Search PubMed for articles
Cardiovascular Institute (CVI)
Institute for Translational Medicine and Therapeutics (ITMAT)
Education:
B.A. (Environmental Sciences)
University of Virginia, Charlottesville, VA, 1992.
M.D. (Medicine)
Medical College of Virginia, Richmond, VA, 1997.
M.S. (Translational Research)
University of Pennsylvania School of Medicine, Philadelphia, PA, 2008.
Permanent linkB.A. (Environmental Sciences)
University of Virginia, Charlottesville, VA, 1992.
M.D. (Medicine)
Medical College of Virginia, Richmond, VA, 1997.
M.S. (Translational Research)
University of Pennsylvania School of Medicine, Philadelphia, PA, 2008.
Description of CVI Expertise
CVI Program Unit(s):Lipid / Atherosclerosis / CAD / ACS / Prevention
CVI Research Description:
I am interested in the treatment of atherogenic dyslipidemia, and have a particular interest in the mechanism of action and adverse effects of nicotinic acid.
Selected Publications
The AIM-HIGH Investigators: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy. NEJM 11 2011.AIM-HIGH Investigators: The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol Rationale and study design. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH). Am.Heart J 161(3): 471-7, 3 2011.
The AIM-HIGH Investigators: The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: impact on Global Health outcomes (AIM-HIGH) trial. Am.Heart J 161(3): 538-543, 3 2011.
Dunbar RL, Gelfand JM: Seeing red: flushing out instigators of niacin-associated skin toxicity. J.Clin.Invest 120(8): 2651-5, August 2010.
Burke MF, Dunbar RL, Rader DJ: Could exercise metabolomics pave the way for gymnomimetics? Sci.Transl.Med. 2(41): 1-3, July 2010.
Dunbar R, Gadi R, Baer A, Goel H, Baber A, Rehan M, Rader D, Millar J: Fenofibric and Nicotinic Acid Progressively Suppress Postprandial Triglyceridemia in Statin-Treated Patients with Low High-Density Lipoprotein Cholesterol [Oral Presentation] J Am Coll Cardiol March 2010 Notes: 59th American College of Cardiology Scientific Conference, Atlanta, GA, March, 2010.
Dunbar R, Gadi R, Baer A, Gupta A, Javed A, Lord C, Rader D, Millar J: Triple Therapy with Statin, Fibrate (Trilipix) and Niacin Raises High-Density Lipoprotein Cholesterol Without Changing Apolipoprotein A-I Levels [Oral Presentation] J Am Coll Cardiol(Supplement), March 2010 Notes: 59th American College of Cardiology Scientific Conference, Atlanta, GA, March, 2010.
Boston RC, Moate PJ, Roche J, Dunbar R, Ward G: Techniques to facilitate metabolic modeling with reference to dairy cows. 7th International Workshop on Modelling Nutrient Digestion and Utilisation in Farm Animals, Paris, France, 10-12 September, 2009. Sauvant D, Milgen Jv, Faverdin P, Friggens N (eds.). Wageningen Academic Publishers, Page: 55-62, 2010.
Dunbar R, Bloedon L, Gadi R, Duffy D, Baer A, Sasiela W, Rader D, Cuchel M: Impact of high doses of the MTP-inhibitor, AEGR-733, on the single-dose pharmacokinetics of Atorvastatin and Rosuvastatin [Poster Presentation] Atherosclerosis Supplements 10(2), June, 2009 Notes: XV International Symposium on Atherosclerosis 2009, Boston, MA, June, 2009.
Dunbar R, Bloedon L, Gadi R, Movva R, Baer A, Parris M, Sasiela W, Rader D, Cuchel M: Impact of the MTP-inhibitor AEGR-733 on the single-dose pharmacokinetics of extended-release niacin [Poster Presentation] Atherosclerosis Supplements 10(2), June 2009 Notes: XV International Symposium on Atherosclerosis 2009, Boston, MA, June, 2009.